Vivoryon Therapeutics N.V.
Save
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Vivoryon Therapeutics N. V., a clinical stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta.

Similar securities

Based on sector and market capitalization

Report issue